NuCana
Price & Volume
Stats
See more52W Range | $1.33-$250 |
Market Cap | $8.1M |
Shares Short | 168,450 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
News
See moreYahoo Finance • 26 days ago
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading
Yahoo Finance • last month
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Yahoo Finance • 4 months ago
NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma
Yahoo Finance • 5 months ago
NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update
About
CEO | Mr. Hugh Stephen Griffith |
Address | 3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 10 |
